Category:
Prophylactic Biological Products
CAS NO:
1220127-57-1
Standard:
ChP,
Imatinib Mesylate is a tiradine kinase inhibitor synthesized via condensation of 4-methylamino-3-chloro-N-(4-methylpyridin-2-yl)benzamide with methanesulfonic acid. It functions as a targeted therapy for malignancies driven by BCR-ABL fusion proteins.
Contraindicated in severe hepatic impairment without dose adjustment. Requires storage below 25°C in dry, light-resistant containers to maintain stability. Strict occupational exposure limits apply during synthesis due to cytotoxicity risks.